FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/076184 [Registered on: 04/11/2024] Trial Registered Prospectively
Last Modified On: 04/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Preventive 
Study Design  Other 
Public Title of Study   A study on prevention of Type 2 Diabetes Mellitus (T2DM) among prediabetes steel plant employees 
Scientific Title of Study   "“EFFECTIVENESS OF NURSE-LED INTERVENTION PACKAGE (NLIP) ON KNOWLEDGE, ATTITUDE, EXPRESSED PRACTICE AND BIO-PHYSIOLOGICAL PARAMETERS REGARDING PREVENTION OF TYPE-2 DIABETES MELLITUS (T2DM) AMONG PREDIABETIC EMPLOYEES OF ROURKELA STEEL PLANT(RSP) ODISHA,INDIA". 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Nabanita Jena 
Designation  Vice Principal 
Affiliation  Nurses Training Institute IGH RSP SAIL 
Address  Vice Principal Office Nurses Training Institute Ispat General Hospital Rourkela Steel Plant Rourkela

Sundargarh
ORISSA
769005
India 
Phone  9437247529  
Fax    
Email  nabanitajena@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr A Maria Therese 
Designation  Vice Principal 
Affiliation  MTPG&RIHS 
Address  College Of Nursing MTPG&RIHS Puducherry

Pondicherry
PONDICHERRY
605006
India 
Phone  9894141223  
Fax    
Email  dr.maria163@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sushil Kumar 
Designation  Consultant, Medicine 
Affiliation  RSP,SAIL 
Address  Ispat General Hospital RSP SAIL

Sundargarh
ORISSA
769005
India 
Phone  8895500765  
Fax    
Email  skumar.dr90@gmail.com  
 
Source of Monetary or Material Support  
Nurses Training Institute Ispat General Hospital Rourkela Steel Plant ROURKELA Odisha India Pincode 769005 
 
Primary Sponsor  
Name  Nabanita Jena 
Address  Nurses Training Institute Ispat General Hospital Rourkela Odisha India Pincode 769005 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Nabanita Jena  Ispat General Hospital, Rourkela Steel Plant  Room no -8, Medicine OPD,Endocrinology department,Rourkela-769005
Sundargarh
ORISSA 
9437247529

nabanitajena@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
ISTITUTIONAL REVIEW BOARD,ISPAT GENERAL HOSPITAL, ROURKELA, ODISHA  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: E08-E13||Diabetes mellitus,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Not Applicable  Not Applicable 
Intervention  Nurse Led Intervention Package(NLIP)  A structured educational and counselling session will be prepared by the investigator to educate the Prediabetic Employees. A Video for 35- 40 minutes on prevention of Diabetics will be developed . The education focused on the followings -assessment, diagnosis, life style management like diet, physical activity (weight control measures and exercise), quite smoking and restricting alcohol consumption with regard to prevention of Type 2 Diabetes Mellitus. Counselling will be given on any personal issues and doubts will be clarified so that clients will understand the prevention of Diabetes. At the end of the 30th day, 60th day and 90th day the post test 1, 2, 3 will be carried out to assess the level of knowledge, Attitude, Practice among the Prediabetes RSP employees with the help of same tool.  
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Employees of Rourkela Steel Plant who
Were in the age group of 30- 60 years
Had clinically diagnosed with pre diabetes (medical record showing FBS more than 100 to 125 mg/dl, HbA1c 5.7 to 6.5)
Had body weight [over weight (BMI greater than or equal to 25) or obese (BMI greater than or equal to 30)]
Understand English or Local language
Willing to participate in the study
Present during the data collection 
 
ExclusionCriteria 
Details  Employee with type 1, type 2 and gestational diabetes.
People with severe cognitive impairment or physical impairment and terminally ill people.
Had evidence of a serious medical illness.
 
 
Method of Generating Random Sequence   Other 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To evaluate the effectiveness of Nurse-Led Intervention Package (NLIP) on knowledge, Attitude, expressed practice and Bio physiological parameters regarding prevention of Type 2 Diabetes Mellitus among Prediabetes employees of Rourkela Steel Plant after intervention in the experimental group.  1 month, 2 month, 3 months interval data will be collected 
 
Secondary Outcome  
Outcome  TimePoints 
To associate effectiveness of Nurse-Led Intervention Package (NLIP) on knowledge, Attitude, expressed practice and Bio physiological parameters among Prediabetes employees of Rourkela Steel Plant with their selected socio demographic variables  1 month, 2 month, 3 months interval data will be collected 
To correlate the post-test knowledge score with Attitude, expressed practice and Bio physiological parameters among Prediabetes employees of Rourkela Steel Plant in the experimental group  1 month, 2 month, 3 months interval data will be collected 
 
Target Sample Size   Total Sample Size="150"
Sample Size from India="150" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   07/11/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Open to Recruitment 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details
Modification(s)  
N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary
Modification(s)  


Diabetes is one of the main fast-growing Non-communicable Disease (NCD) risk to global public health. Prediabetes is a condition in which individuals have blood glucose levels higher than normal but not high enough to be classified as diabetes. People with prediabetes have an increased risk of Type 2 diabetes. An estimated 34% of adults have prediabetes. Prediabetes is now recognized as a reversible condition that increases an individual’s risk for development of diabetes.. The Nurse-led Intervention Package (NLIP) is educational programme delivered through video assisted teaching on Prediabetes and prevention of T2DM where close involvement of patients and caregivers is encouraged. Researcher will provide education, counselling, guidance and monitor the patient condition regularly in order to prevention of the occurrence of Type 2 Diabetes Mellitus.  The researcher, from her experience observed that many employees of Rourkela Steel Plant, Odisha diagnosed as Prediabetes and found that they are not following healthy life style like not monitoring the blood glucose level regularly, not taking balance diet, not doing physical activity regularly, not maintaining normal BMI and not adhering to the treatment strategies properly. Due to these unhealthy habits finally, they are developing type 2 Diabetes and experiencing its severe complications.

Developing Nurse-led Intervention package (NLIP) can help people to manage their Prediabetes condition and reduce the risk of developing T2DM and its complications. A Nurse-led Intervention package (NLIP) can be cost effective and efficient way to improve patient outcome.


 
Close